Covered recipient · General Payments record
JOHN R TODD
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$3,496.95
- Reported across 163 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $531.40 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $270.64 | 12 |
| Shionogi Inc | $62.24 | 4 |
| Merck Sharp & Dohme Corporation | $57.32 | 3 |
| Astellas Pharma US Inc | $41.19 | 2 |
| Melinta Therapeutics, Inc. | $26.28 | 1 |
| Insmed, Inc. | $20.43 | 1 |
| Gilead Sciences, Inc. | $19.48 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.25 | 1 |
| La Jolla Pharmaceutical Company | $16.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.44 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229495 | CMS |
| ABBVIE INC. | $29.48 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229497 | CMS |
| ABBVIE INC. | $10.13 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229499 | CMS |
| ABBVIE INC. | $26.60 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229501 | CMS |
| ABBVIE INC. | $29.24 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229503 | CMS |
| ABBVIE INC. | $29.99 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229505 | CMS |
| ABBVIE INC. | $26.39 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229507 | CMS |
| ABBVIE INC. | $24.33 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229509 | CMS |
| ABBVIE INC. | $14.30 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229511 | CMS |
| ABBVIE INC. | $13.56 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229513 | CMS |
| ABBVIE INC. | $23.23 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229515 | CMS |
| ABBVIE INC. | $21.95 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106229517 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.25 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000853 | CMS |
| Astellas Pharma US Inc | $16.89 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139278760 | CMS |
| Astellas Pharma US Inc | $24.30 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139352987 | CMS |
| Gilead Sciences, Inc. | $19.48 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133820965 | CMS |
| Insmed, Inc. | $20.43 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089571530 | CMS |
| La Jolla Pharmaceutical Company | $16.57 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154251540 | CMS |
| Melinta Therapeutics, LLC | $26.28 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140485389 | CMS |
| Merck Sharp & Dohme LLC | $17.84 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141868141 | CMS |
| Merck Sharp & Dohme LLC | $16.18 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141692642 | CMS |
| Merck Sharp & Dohme LLC | $23.30 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141692644 | CMS |
| Shionogi Inc | $18.43 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338738 | CMS |
| Shionogi Inc | $13.83 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338762 | CMS |
| Shionogi Inc | $13.34 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338784 | CMS |
| Shionogi Inc | $16.64 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154338830 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.